Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Berry

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
JCO Global Oncology|May 27, 2022
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer RegistryDon Thiwanka Wijeratne, Sanjeeva Gunasekara, Christopher M Booth, et al.
The New England Journal of Medicine|March 22, 2013
Closure of patent foramen ovale versus medical therapy after cryptogenic strokeJohn D Carroll, Jeffrey L Saver, David E Thaler, et al.
The Oncologist|September 23, 2023
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public HealthcareSarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 3, 2025
Professional Development Among African Oncologists: Examining Professional Development Activities, Satisfaction Levels, Barriers, and EnablersEmiola O Olapade-Olaopa, Miriam Mutebi, Nicholas Cofie, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 10, 2020
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methodsS Iris Deeds, Andrew Barreto, Jordan Elm, et al.
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independentAnthony J Mutsaers, Giulio Francia, Shan Man, et al.
Microorganisms|June 27, 2025
Implementing Wastewater-Based Epidemiology for Long-Read Metagenomic Sequencing of Antimicrobial Resistance in Kampala, UgandaWilliam Strike, Temitope O C Faleye, Brian Lubega, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Breaking Down Barriers to Detection and Care in Early-Age-Onset Colorectal Cancer in CanadaMichael J Raphael, Petra Wildgoose, Filomena Servidio-Italiano, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
JCO Global Oncology|May 27, 2022
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer RegistryDon Thiwanka Wijeratne, Sanjeeva Gunasekara, Christopher M Booth, et al.
The New England Journal of Medicine|March 22, 2013
Closure of patent foramen ovale versus medical therapy after cryptogenic strokeJohn D Carroll, Jeffrey L Saver, David E Thaler, et al.
The Oncologist|September 23, 2023
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public HealthcareSarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 3, 2025
Professional Development Among African Oncologists: Examining Professional Development Activities, Satisfaction Levels, Barriers, and EnablersEmiola O Olapade-Olaopa, Miriam Mutebi, Nicholas Cofie, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 10, 2020
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methodsS Iris Deeds, Andrew Barreto, Jordan Elm, et al.
The Lancet. Oncology|June 11, 2016
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trialDavid Cella, Viktor Grünwald, Paul Nathan, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independentAnthony J Mutsaers, Giulio Francia, Shan Man, et al.
Microorganisms|June 27, 2025
Implementing Wastewater-Based Epidemiology for Long-Read Metagenomic Sequencing of Antimicrobial Resistance in Kampala, UgandaWilliam Strike, Temitope O C Faleye, Brian Lubega, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Breaking Down Barriers to Detection and Care in Early-Age-Onset Colorectal Cancer in CanadaMichael J Raphael, Petra Wildgoose, Filomena Servidio-Italiano, et al.
Pageof 15